ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
1,2,Renal colic,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
2,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
3,1,Factor VIII inhibition,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
3,2,Haemarthrosis,Arthropathies NEC,Joint disorders,Musc,N
3,3,Muscle haemorrhage,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
4,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4,2,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
4,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
4,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
5,1,Left ventricular failure,Left ventricular failures,Heart failures,Card,N
5,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
5,3,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
6,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
6,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
6,3,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
6,4,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
6,5,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
6,6,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
7,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
7,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
7,3,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
8,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
8,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
8,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
8,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
9,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
10,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
11,1,Factor VIII inhibition,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
11,2,Pneumonia staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,Y
12,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
12,2,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
13,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
14,1,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
15,1,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
15,2,Nonspecific reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
16,1,Factor VIII inhibition,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
17,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
18,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
18,2,Wrong patient received product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
19,1,Factor VIII inhibition,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
19,2,Hepatic artery thrombosis,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,Y
20,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
20,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
20,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
20,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
20,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
20,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
20,7,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
21,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
21,2,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
21,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
21,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
21,5,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
21,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
21,7,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
22,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
22,2,Glassy eyes,General signs and symptoms NEC,General system disorders NEC,Genrl,N
22,3,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
22,4,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
22,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
22,6,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
23,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
23,2,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
23,3,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
23,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
23,5,Glassy eyes,General signs and symptoms NEC,General system disorders NEC,Genrl,N
23,6,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
23,7,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
23,8,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
23,9,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
23,10,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
24,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
25,1,Cardiac ventricular thrombosis,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
26,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
26,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
27,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
27,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
28,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
29,1,Haemarthrosis,Arthropathies NEC,Joint disorders,Musc,N
29,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
30,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
30,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
30,3,HIV infection,Retroviral infections,Viral infectious disorders,Infec,N
30,4,Hepatitis A,Hepatitis virus infections,Viral infectious disorders,Infec,N
30,5,Hepatitis B,Hepatitis virus infections,Viral infectious disorders,Infec,N
30,6,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
30,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
31,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
32,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
32,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
33,1,Haemarthrosis,Arthropathies NEC,Joint disorders,Musc,N
34,1,Haemarthrosis,Arthropathies NEC,Joint disorders,Musc,N
35,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
36,1,Haemarthrosis,Arthropathies NEC,Joint disorders,Musc,N
36,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
37,1,Haemarthrosis,Arthropathies NEC,Joint disorders,Musc,N
38,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
38,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
39,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
39,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
40,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
40,2,Vascular device infection,Vascular infections,Infections - pathogen unspecified,Infec,N
41,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
42,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
42,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
43,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
43,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
43,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
44,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
45,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
45,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
46,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
46,2,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
46,3,Injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
46,4,Thrombotic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
